As AstraZeneca puts its COVID-19 vaccine study on hold, experts say don’t worry, just wait
By
Kimberly Marselas
Sep 09, 2020
A vaccine participant in the United Kingdom developed a rare inflammatory disease, causing AstraZeneca to pause its Phase 3 COVID-19 trials.
Clinical Briefs for Tuesday, June 2
By
Alicia Lasek
Jun 01, 2020
First federal count: more than 25,000 coronavirus deaths in nursing homes … AstraZeneca’s heart drug for high-risk patients receives FDA approval … Senior living operator balances safety, quality...
Seroquel generics okay, appeals court says
May 01, 2013
AstraZeneca is not entitled to more exclusivity with its antischizophrenic medication, an appeals court agreed last week. The company had claimed its drug, Seroquel, deserved another three-year extension...
Seroquel maker to pay $5.5M in latest settlement related to off-label use of the antipsychotic drug
By
McKnight's Staff
Feb 13, 2013
Drugmaker AstraZeneca recently settled a lawsuit with the state of Kentucky over allegations of improperly marketing its atypical antipsychotic drug Seroquel. Under the settlement, the London-based pharmaceutical...
AstraZeneca pays $68.5 million in Seroquel marketing case
Mar 14, 2011
Pharmaceutical giant AstraZeneca on Thursday agreed to pay $68.5 million to settle allegations that it inappropriately marketed the drug Seroquel for off-label uses, multiple states’ authorities...